Proshares UltraPro Nasdaq Biotechnology (UBIO) declined -5.37% or -1.58 to $27.87. It is near 34684 shares traded, which is 65.83% compare to the average total volume 52686. The market cap of UBIO is $30.65 million. The year to date change is 39.21%. The 52 week price range is from $15.76 to $45.28. Price of UBIO have changed 3.73% during last week. It have changed 5.94% over last month, 19.96% over last 3 months, -23.59% over last 6 months and -15.37% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for UBIO is 25.80. It is -7.43% below current price. The 200-day Moving Averages for UBIO is 32.77. It is 17.58% above current price. The 52-week High is 45.28. It is 62.47% from the current price. The 52-week Low is 15.76. It is -43.45% from current price.
There are some statistics of UBIO. It is has market cap $30.65 million. The share outstanding is 1.10 million. The average volume is 52686. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of UBIO is 1.51%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of UBIO is -4.90%.